John Kamara
Impact in
- Infectious Diseases top 2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
-
- Venous Thromboembolism Diagnosis and Management
Papers in
-
- COVID-19 Clinical Research Studies 5
- Co-authors
- Samson Oghenetsovwe Oyibo (1 shared paper)Radim Líčeník (1 shared paper)Suresh Ponnusamy (1 shared paper)
- Journals
- The Lancet (5 papers)Cureus (2 papers)
- Partner nations
- United KingdomVietnamNepal
In The Last Decade
John Kamara
6 papers receiving 1.1k citations
John Kamara's Hit Papers
Peers
Comparison fields: 5 of 44
- Infectious Diseases 744
- Internal Medicine 15
- Obstetrics and Gynecology 17
- Information Systems and Management 8
- Statistics and Probability 13
Countries citing papers authored by John Kamara
This map shows the geographic impact of John Kamara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Kamara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Kamara more than expected).
Fields of papers citing papers by John Kamara
This network shows the impact of papers produced by John Kamara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Kamara. The network helps show where John Kamara may publish in the future.
Co-authors
The 3 scholars most cited alongside John Kamara, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Hit paper breakdown → | 2021 | 393 |
| 2 | Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2022 | 282 |
| 3 | Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis Hit paper breakdown → | 2022 | 231 |
| 4 | 2021 | 213 | |
| 5 | 2023 | 84 | |
| 6 | 2023 | 1 | |
| 7 | 2021 | 0 |
About John Kamara
John Kamara is a scholar working on Infectious Diseases, Nuclear Energy and Engineering, Waste Management and Disposal, Organic Chemistry and Surgery, having authored 7 papers that have together received 1.2k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (5 papers). The work is most often cited by research in Infectious Diseases (744 citations), Internal Medicine (15 citations), Obstetrics and Gynecology (17 citations), Information Systems and Management (8 citations) and Statistics and Probability (13 citations). John Kamara has collaborated with scholars based in United Kingdom, Vietnam and Nepal. Frequent co-authors include Samson Oghenetsovwe Oyibo, Radim Líčeník and Suresh Ponnusamy. Their work appears in journals such as The Lancet and Cureus.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.